SVB Securities analyst Jonathan Chang reiterated a Hold rating on ImmunoGen (IMGN - Research Report) on August 31 and set a price target of $4.00. The company's shares closed yesterday at $5.51.According to TipRanks, Chang is an analyst with an average return of -11.2% and a 28.31% success rate. Chang covers the Healthcare sector, focusing on stocks such as Immatics, ImmunoGen, and Kura Oncology.In addition to SVB Securities, ImmunoGen also received a Hold from Piper Sandler's Joseph Catanzaro in a report issued on August 31. However, yesterday, H.C. Wainwright maintained a Buy rating on ImmunoGen (NASDAQ: IMGN).
https://www.tipranks.com/news/blurbs/immunogen-imgn-receives-a-hold-from-svb-securities?utm_source=advfn.com&utm_medium=referral
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more ImmunoGen Charts.
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more ImmunoGen Charts.